Prospective Evaluation of the Embolic Agent Bead Block in the Treatment of Uterine Leiomyomas with Uterine Artery Embolization: A Phase II Study

2010 ◽  
Vol 21 (4) ◽  
pp. 484-489 ◽  
Author(s):  
Howard B. Chrisman ◽  
Sabeen Dhand ◽  
Shankar Rajeswaran ◽  
Paul Nikolaidis ◽  
Robert L. Vogelzang ◽  
...  
Keyword(s):  
Phase Ii ◽  
Uterine Artery Embolization ◽  
Uterine Artery ◽  
Phase Ii Study ◽  
Uterine Leiomyomas ◽  
Embolic Agent ◽  
Prospective Evaluation ◽  
Artery Embolization

scholarly journals Risk factors for poor hemostasis of prophylactic uterine artery embolization before curettage in cesarean scar pregnancy

2020 ◽  
Vol 48 (10) ◽  
pp. 030006052096437
Author(s):  
Hongan Tian ◽  
Shunzhen Li ◽  
Wanwan Jia ◽  
Kaihu Yu ◽  
Guangyao Wu
Keyword(s):  
Risk Factors ◽  
Blood Supply ◽  
Uterine Artery Embolization ◽  
Uterine Artery ◽  
Embolic Agent ◽  
Artery Embolization ◽  
Cesarean Scar Pregnancy ◽  
Cesarean Scar ◽  
Hemorrhage Volume ◽  
Gestational Sac

Objective To observe the hemostatic effect of prophylactic uterine artery embolization (UAE) in patients with cesarean scar pregnancy (CSP) and to examine the risk factors for poor hemostasis. Methods Clinical data of 841 patients with CSP who underwent prophylactic UAE and curettage were retrospectively analyzed to evaluate the hemorrhage volume during curettage. A hemorrhage volume ≥200 mL was termed as poor hemostasis. The risk factors of poor hemostasis were analyzed and complications within 60 days postoperation were recorded. Results Among the 841 patients, 6.30% (53/841) had poor postoperative hemostasis. The independent risk factors of poor hemostasis were gestational sac size, parity, embolic agent diameter (>1000 μm), multivessel blood supply, and incomplete embolization. The main postoperative complications within 60 days after UAE were abdominal pain, low fever, nausea and vomiting, and buttock pain, with incidence rates of 71.22% (599/841), 47.44% (399/841), 39.12% (329/841), and 36.39% (306/841), respectively. Conclusions Prophylactic UAE before curettage in patients with CSP is safe and effective in reducing intraoperative hemorrhage. Gestational sac size, parity, embolic agent diameter, multivessel blood supply, and incomplete embolization of all arteries supplying blood to the uterus are risk factors of poor hemostasis.

Uterine Artery Embolization under Electroacupuncture for Uterine Leiomyomas

2009 ◽  
Vol 20 (7) ◽  
pp. 863-870 ◽  
Author(s):  
João M. Pisco ◽  
Mitsuharu Tsuchiya ◽  
Tiago Bilhim ◽  
Marisa Duarte ◽  
Daniela Santos ◽  
...  
Keyword(s):  
Uterine Artery Embolization ◽  
Uterine Artery ◽  
Uterine Leiomyomas ◽  
Artery Embolization

scholarly journals Development of a Model for the Prediction of Treatment Response of Uterine Leiomyomas after Uterine Artery Embolization

2018 ◽  
Vol 15 (14) ◽  
pp. 1771-1777 ◽  
Author(s):  
Youn-Jee Chung ◽  
So-Yeon Kang ◽  
Ho Jong Chun ◽  
Sung Eun Rha ◽  
Hyun Hee Cho ◽  
...  
Keyword(s):  
Treatment Response ◽  
Uterine Artery Embolization ◽  
Uterine Artery ◽  
Uterine Leiomyomas ◽  
Artery Embolization

Uterine Artery Embolization of Uterine Leiomyomas: Predictive MRI Features of Volumetric Response

2021 ◽  
Vol 216 (4) ◽  
pp. 967-974
Author(s):  
Lutfi Ali S. Kurban ◽  
Hesham Metwally ◽  
Mudar Abdullah ◽  
Abdurzag Kerban ◽  
Abderrahim Oulhaj ◽  
...  
Keyword(s):  
Uterine Artery Embolization ◽  
Uterine Artery ◽  
Uterine Leiomyomas ◽  
Artery Embolization ◽  
Mri Features ◽  
Volumetric Response

Uterine Artery Embolization Versus Occlusion for Uterine Leiomyomas: A Pilot Randomized Clinical Trial

2008 ◽  
Vol 15 (3) ◽  
pp. 301-307 ◽  
Author(s):  
Eve Cunningham ◽  
Lorena Barreda ◽  
Michael Ngo ◽  
Keith Terasaki ◽  
Malcolm G. Munro
Keyword(s):  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
Uterine Artery Embolization ◽  
Uterine Artery ◽  
Uterine Leiomyomas ◽  
Artery Embolization
Sign in / Sign up

Export Citation Format

Share Document